CA
RCKT icon

Cliff Asness’s Rocket Pharmaceuticals RCKT Stock Holding History

Cliff Asness’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.6M Buy
3,386,162
+316,232
+10% +$1.05M ﹤0.01% 1477
2026
Q1 		$11M Buy
3,069,930
+2,366,402
+336% +$9.41M 0.01% 1296
2025
Q4 		$2.47M Sell
703,528
-169,719
-19% -$581K ﹤0.01% 2006
2025
Q3 		$2.85M Buy
873,247
+95,579
+12% +$301K ﹤0.01% 1772
2025
Q2 		$1.91M Buy
777,668
+614,046
+375% +$3.11M ﹤0.01% 1803
2025
Q1 		$1.09M Buy
163,622
+97,758
+148% +$966K ﹤0.01% 1968
2024
Q4 		$828K Buy
65,864
+46,956
+248% +$707K ﹤0.01% 1994
2024
Q3 		$349K Buy
+18,908
New +$387K ﹤0.01% 2323
2024
Q2 		– Sell
-10,118
Closed -$273K – 2664
2024
Q1 		$273K Buy
10,118
+2,060
+26% +$58.5K ﹤0.01% 2159
2023
Q4 		$241K Buy
+8,058
New +$178K ﹤0.01% 2146

Other funds holding RCKT

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NM
Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Cliff Asness's RCKT Position: Q2 2026 in Review

Cliff Asness increased its Rocket Pharmaceuticals (RCKT) stake by 10% in Q2 2026, buying an estimated $1.05M and bringing the position to 3,386,162 shares worth $11.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

Cliff Asness first reported a position in RCKT in Q4 2023 and has held it in 10 quarters since. 178 funds tracked by Wall St. Rank hold RCKT as of Q2 2026.

  • Cliff Asness held 3,386,162 shares of Rocket Pharmaceuticals worth $11.6M as of Q2 2026.
  • Cliff Asness bought 316,232 Rocket Pharmaceuticals shares in Q2 2026, an estimated $1.05M.
  • Rocket Pharmaceuticals made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #1477 holding.
  • Cliff Asness first reported a position in Rocket Pharmaceuticals in Q4 2023 and has held it in 10 quarters since.
  • 178 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.